BioCentury
ARTICLE | Clinical News

Aeterna Zentaris preclinical data

December 6, 2010 8:00 AM UTC

In mouse xenograft models of colon, lung, prostate and endometrial cancers, 45 mg/kg/day oral AEZS-129 for 4 weeks significantly inhibited tumor growth vs. vehicle-treated controls (p<0.05 for all). A...